Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study on the Combined Detection of Plasma GNB4 and Riplet Gene Methylation for Monitoring Primary Liver Cancer Recurrence

NCT07466602 is registered in ClinicalTrials.gov with Wuhan Ammunition Life-tech Co., Ltd as lead sponsor.

NCT NCT07466602
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07466602 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study on the Combined Detection of Plasma GNB4 and Riplet Gene Methylation for Monitoring Primary Liver Cancer Recurrence
Lead sponsor
Wuhan Ammunition Life-tech Co., Ltd
Phase
Observational
Overall status
Recruiting
Start date
September 2, 2025
Completion date
December 31, 2027
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary liver cancer